Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Sugammadex Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

83 API Suppliers, 30 USDMF, 9 JDMF, 13 EU WC, 25 KDMF, 27 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

171 FDF Dossiers, 18 FDA Orange Book, 122 Europe, 4 Canada, 16 South Africa, 11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 200MG BASE/2ML (EQ 100MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Actylis

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 34 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

15 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 4 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 3 Others

$ Xls

Filters

SOLUTION;INTRAVENOUS - EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Sugammadex Sodium

Sugammadex Sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

83 API Suppliers

30 USDMF

9 JDMF

13 EU WC

25 KDMF

27 NDC API

50 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

171 FDF Dossiers

18 FDA Orange Book

122 Europe

4 Canada

16 South Africa

11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Actylis

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

34 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices

11 Annual Reports

MARKET PLACE

15 APIs

6 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Exclusivities

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP

3 Others

Filters